Importantly, novel TRAP-1 antagonists are shown to cause sudden collapse of mitochondrial functions and selective tumor cell death, suggesting that this pathway may represent a novel molecular target to improve anticancer therapy. The gene discussed is TRAP1; the disease is neoplasm.